NICE thumbs up for new Astellas bladder drug

NICE thumbs up for new Astellas bladder drug…

---

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) and Astellas Pharma Inc. Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced that additional data from t…

---

OSI Pharma, Long Island Biotech Bellwether, Shut Down by Astellas

Ben Fidler OSI Pharmaceuticals became the home-grown beacon of Long Island, NY’s biotech scene behind the lung cancer drug erlotinib (Tarceva), which was so successful that led Japan’s A…

---

Astellas outlines plan to reshape its research framework, reallocate resources

Tokyo-based Astellas Pharma has announced plans to reshape its research framework by introducing new initiatives to enhance the ability to generate innovative drugs.

---